Cargando…
Differences in sensitivity to neoadjuvant chemotherapy among invasive lobular and ductal carcinoma of the breast and implications on surgery–A systematic review and meta-analysis
Meta-analysis of >87,000 patients demonstrates that patients with invasive lobular carcinoma of the breast are far less likely to achieve pCR of the breast or axilla compared to their ductal counterparts, receive less BCS and more frequently return positive margins. BACKGROUND: Neoadjuvant chemot...
Autores principales: | O'Connor, Dómhnall J., Davey, Matthew G., Barkley, Laura R., Kerin, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649952/ https://www.ncbi.nlm.nih.gov/pubmed/34864494 http://dx.doi.org/10.1016/j.breast.2021.11.017 |
Ejemplares similares
-
Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas
por: Delpech, Y, et al.
Publicado: (2013) -
Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer
por: Truin, W., et al.
Publicado: (2015) -
Change in Main Histological Type of Invasive Breast Cancer From Ductal to Lobular Carcinoma by Neoadjuvant Chemotherapy
por: Okubo, Takako, et al.
Publicado: (2023) -
Malignant Phyllodes Tumour with Liposarcomatous Differentiation, Invasive Tubular Carcinoma, and Ductal and Lobular Carcinoma In Situ: Case Report and Review of the Literature
por: Abdul Aziz, Mardiana, et al.
Publicado: (2010) -
Mixed ductal‐lobular carcinomas: evidence for progression from ductal to lobular morphology
por: McCart Reed, Amy E, et al.
Publicado: (2018)